⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 3, 2024Open Access

Supplementary Methods S8 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study

David J. Pinato Antonio D’Alessio Claudia Angela Maria Fulgenzi Alexandra Emilia Schlaak Ciro Celsa Saskia Killmer Jesús Miguéns Blanco Caroline Ward Charalampos‐Vlasios Stikas Mark R. Openshaw Nicole Acuti Georgios Nteliopoulos Cristina Balcells Hector C. Keun Robert Goldin Paul J. Ross Alessio Cortellini Robert Thomas Anna-Mary Young Nathan Danckert Paul Tait Julian R. Marchesi Bertram Bengsch Rohini Sharma

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Methods 8. Immune subtype and related number of genes profiled using the NanoString PanCancer Immune panel.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pinato et al. (2024) studied this question.

synapsesocial.com/papers/68e66839b6db6435875f3dcd https://doi.org/10.1158/1078-0432.25956595.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Methods S8 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
2Supplementary Methods S7 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
3Supplementary Methods S7 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
4Supplementary Methods S6 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
5Supplementary Methods S6 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024

Supplementary Methods S5 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
Supplementary Methods S5 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
Supplementary Figure S11 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024